Outcome of Reinduction Chemotherapy with a Modified Dose of Idarubicin for Children with Marrow-Relapsed Acute Lymphoblastic Leukemia: Results of the Childhood Acute Lymphoblastic Leukemia (CALL)-0603 Study

This multicenter, prospective trial was conducted to develop an effective and safe reinduction regimen for marrow-relapsed pediatric acute lymphoblastic leukemia (ALL) by modifying the dose of idarubicin. Between 2006 and 2009, the trial accrued 44 patients, 1 to 21 years old with first marrow-relap...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Korean Med Sci
Main Authors: Koh, Kyung-Nam, Im, Ho Joon, Kim, Hyery, Kang, Hyoung Jin, Park, Kyung Duk, Shin, Hee Young, Ahn, Hyo Seop, Lee, Ji Won, Yoo, Keon Hee, Sung, Ki Woong, Koo, Hong Hoe, Lim, Young Tak, Park, Jun Eun, Park, Byung-Kiu, Park, Hyeon Jin, Seo, Jong Jin
Formato: Artigo
Idioma:Inglês
Publicado em: The Korean Academy of Medical Sciences 2017
Assuntos:
Original Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5334163/
https://ncbi.nlm.nih.gov/pubmed/28244291
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3346/jkms.2017.32.4.642
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados